source
- AbbVie completes $10.9 billion acquisition of Apogee Therapeutics as UK launches drug pricing pilotAbbVie, the Chicago-based pharmaceutical company, finalized its purchase of Apogee Therapeutics for $10.9 billion last month, ending a multi-year negotiation process. The transaction brings Apogee…
- FDA approves 23 new drugs in first half, marking best pace in three years despite staff cutsThe FDA announced that it has approved 23 novel drugs during the first half of 2026, the strongest approval count in three years. The approvals come after the Trump administration reduced FDA staf…